ProCE Banner Activity

CE

Delivering Patient-Centered, Equitable Care in Anemia of CKD: Expert Insights on Translating Progress to Practice to Minimize Burden of Disease and Healthcare Disparities

Video

In this program, 2 experts provide insights on the undertreatment of anemia in CKD and potential novel treatment options along with strategies to address health disparities.

Pharmacists: 1.50 contact hours (0.15 CEUs)

Released: April 28, 2023

Expiration: April 27, 2024

No longer available for credit.

Share

Faculty

Branden D. Nemecek

Branden D. Nemecek, PharmD, BCPS

Associate Professor
Pharmacy Practice
Duquesne University
Clinical Pharmacist
University of Pittsburgh Medical Center Mercy Hospital
Pittsburgh, Pennsylvania

Michelle M. Richardson

Michelle M. Richardson, PharmD, BCPS

Special and Scientific Staff
Tufts Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Provided by

This activity is provided by ProCE, LLC

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GSK.

GSK

Target Audience

This activity is intended for pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with anemia of CKD, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners about current and emerging treatment options for anemia of CKD and strategies to minimize healthcare disparities in the management of patients with anemia and CKD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the underrecognition and undertreatment of anemia in patients with CKD and the subsequent burden of disease

  • Recognize the pathophysiology of anemia of CKD

  • Evaluate clinical trial data on the physiologic actions, efficacy, and safety of HIF-PH inhibitors and their potential role in the management of anemia of CKD

  • Incorporate health disparity mitigation strategies into the care of patients with anemia of CKD

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learning with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of ineligible company.

The faculty reported the following relevant financial relationships to products or devices they have with ineligible companies related to the content of this educational activity.

Primary Author

Branden D. Nemecek, PharmD, BCPS

Associate Professor
Pharmacy Practice
Duquesne University
Clinical Pharmacist
University of Pittsburgh Medical Center Mercy Hospital
Pittsburgh, Pennsylvania

Branden D. Nemecek, PharmD, BCPS, has no relevant financial relationships to disclose.

Michelle M. Richardson, PharmD, BCPS

Special and Scientific Staff
Tufts Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Michelle Richardson, PharmD, BCPS, has no relevant financial relationships to disclose.

The planners and content peer reviewers from ProCE, LLC do not have any relevant financial relationships to disclose.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities .

Accreditation

Pharmacists

 

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-23-005-H01-P has been assigned to this home study application-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.